Results 31 to 40 of about 25,199 (174)

Un nou biomarcador per a la detecció del càncer de pròstata en orina [PDF]

, 2011
El càncer de pròstata és el tipus de càncer més freqüent que afecta a la població masculina. El mètode diagnòstic utilitzat actualment és la detecció en sèrum de PSA (antigen prostàtic específic), el tacte rectal i la posterior biòpsia en cas de sospita.
Rigau Resina, Marina
core   +1 more source

Cáncer de próstata y calidad de vida: análisis del cambio en la respuesta a partir de una triangulación entre métodos [PDF]

, 2013
Introduction. The aim of this paper is to describe the changes in the quality of life (QoL) in a group of men with prostate cancer. The three mechanisms involved in the response shift correspond to the reconceptualization, reprioritization and ...
del Valle, Arantza, Serdà, Bernat-Carles   +1 more
core   +2 more sources

Artificial Intelligence Chatbots and Their Responses to Most Searched Spanish Cancer Questions

Cancer Medicine, Volume 14, Issue 21, November 2025.
Artificial intelligence (AI) chatbots are trained using English materials, and their performance in answering Spanish cancer questions is unknown. After comparing the six most popular AI chatbots, we found their answers were generally accurate (but hard to read) and needed more improvement in supporting patients to make cancer‐related decisions ...
En Cheng, Jesus D. Anampa, Carolina Bernabe‐Ramirez, Juan Lin, Xiaonan Xue, Carmen R. Isasi, Alyson B. Moadel‐Robblee, Edward Chu   +7 more
wiley   +1 more source

Cost effectiveness analysis of prostate cancer screening strategies in Germany: A microsimulation study

International Journal of Cancer, Volume 157, Issue 8, Page 1662-1679, 15 October 2025.
What's New? Prostate cancer is a significant health and economic concern in Germany. In particular, screening methods require greater optimisation to prevent overdiagnosis and unnecessary procedures and to ensure clinical benefit. Here, prostate cancer screening strategies were evaluated to determine which are most effective in terms of cost and health
Muchandifunga Trust Muchadeyi, Shuang Hao, Karla Hernandez‐Villafuerte, Shah Alam Khan, Nikolaus Becker, Agne Krilaviciute, Petra Seibold, Roman Gulati, Peter Albers, Michael Schlander, Mark Clements   +10 more
wiley   +1 more source

Antígeno prostático específico como marcador tumoral de adenocarcinoma prostático en pacientes mayores de 50 años en Hospital General Portoviejo

QhaliKay, 2022
El carcinoma prostático se encuentra entre los primeros tipos de tumores más habituales en Ecuador. El objetivo de este trabajo fue analizar los resultados de antígeno prostático específico (PSA) como marcador tumoral de adenocarcinoma prostático en ...
Katiuska Del Rocio Mera Mero, Jorge Washington Pachay Solórzano   +1 more
doaj   +1 more source

Relación de la susceptibilidad genética y de las características anatomopatológicas del cáncer de próstata con los polimorfismos de nucleótido simple [PDF]

, 2012
Actualmente no se disponen de marcadores biológicos específicos para la cáncer de próstata produciéndose en muchas ocasiones biopsias prostáticas innecesarias o un sobretratamientos para cánceres indolentes.
Ruiz Domínguez, Jose Manuel, Universitat Autònoma de Barcelona. Departament de Cirurgia, Universitat Autònoma de Barcelona. Facultat de Medicina   +2 more
core  

Computation of Protein Thermostability and Epistasis

WIREs Computational Molecular Science, Volume 15, Issue 5, September/October 2025.
Conceptual illustration of computational prediction of protein thermostability and mutational epistasis. A neural network algorithm models changes in heat‐induced (un)folding by correlating sequence mutations with variations in free energy. The nonadditive nature of epistatic mutations is metaphorically represented by Orwell's infamous quote from ...
Francesca Peccati, Cristina M. Segovia, Reyes Núñez‐Franco, Gonzalo Jiménez‐Osés   +3 more
wiley   +1 more source

PSA no rastreio do câncer de próstata e a opinião e o conhecimento geral sobre o assunto

Revista Pró-UniverSUS
O câncer de próstata é o segundo câncer mais frequente e é a quinta maior causa de morte entre homens. Em 2009 se estimou que mais da metade dos homens com pelo menos 50 anos se submetia a rastreamento com PSA anualmente e 75% da população fez o exame ...
Felipe de Carvalho Silva, Guilherme da Rocha Pereira, Pedro Silva Chaves, Vitor Augusto Rodrigues Alves, Federico Franscino Nesi, Rodolfo Guimarães Silva   +5 more
doaj   +3 more sources

Endoscopic ultrasound‐guided tissue acquisition for focal liver lesions in patients with a history of multiple primary malignant neoplasms

DEN Open, Volume 5, Issue 1, April 2025.
Abstract Objective This study aimed to investigate the usefulness of endoscopic ultrasound‐guided tissue acquisition (EUS‐TA) for diagnosing focal liver lesions in patients with a history of multiple primary malignant neoplasms. Methods Among patients who underwent EUS‐TA for focal liver lesions between 2016 and 2022, those with a history of multiple ...
Yuichi Takano, Naoki Tamai, Masataka Yamawaki, Jun Noda, Tetsushi Azami, Fumitaka Niiya, Fumiya Nishimoto, Naotaka Maruoka, Tatsuya Yamagami, Masatsugu Nagahama   +9 more
wiley   +1 more source

¿Es el cribado del PSA un método efectivo para la prevención y detección del cáncer de próstata en varones mayores de 50 años? [PDF]

, 2017
Tras el descubrimiento del antígeno prostático específico (PSA), este antígeno se ha generalizado como indicador para el cribado poblacional del cáncer de próstata en las consultas de Atención Primaria.
Ruiz Vázquez, Julia
core